根据肿瘤性激素受体表达评估卵巢癌风险与生存:卵巢癌协会联盟与卵巢肿瘤组织分析联盟的汇总分析
该汇总分析链接19项研究(卵巢癌协会联盟4762例病例、20888例对照;卵巢肿瘤组织分析联盟5737例病例)的流行病学、肿瘤AR/ER/PR表达及生存数据,采用多项逻辑回归和Cox模型分析。结果显示,超重/肥胖与ER-肿瘤风险升高相关(OR 1.53,95%CI 1.18-1.98),子宫切除术与ER+肿瘤风险升高相关(OR 4.99,95%CI 4.27-5.83),绝经后与PR-肿瘤风险升高相关(OR 1.52,95%CI 1.26-1.83),且激素相关因素与生存的关联因受体表达和组织学类型而异。
要点
- 超重/肥胖与ER-肿瘤风险升高相关(OR 1.53,95%CI 1.18-1.98)。
- 子宫切除术与ER+肿瘤风险升高相关(OR 4.99,95%CI 4.27-5.83),且随AR表达而异(P异质性=0.003)。
- 绝经后与PR-肿瘤风险升高相关(OR 1.52,95%CI 1.26-1.83),且随AR和ER表达而异(P异质性均<0.001)。
核心结论
- 上皮性卵巢癌的风险和预后特征因组织学类型和AR/ER/PR表达而异。
- 激素相关因素与上皮性卵巢癌的关联机制需按组织学类型及AR、ER、PR表达进一步研究。
研究设计与样本
- 汇总分析链接卵巢癌协会联盟(OCAC)19项研究(4762例病例、20888例对照)和卵巢肿瘤组织分析联盟(OTTA)5737例病例的流行病学、肿瘤AR/ER/PR表达及生存数据。
- 采用多项逻辑回归估计激素相关因素与肿瘤AR/ER/PR表达之间的比值比(OR)及95%置信区间(CI)。
- 采用Kaplan-Meier曲线和Cox比例风险模型评估按肿瘤AR/ER/PR表达总体及按组织学类型分层的生存。
主要发现
- 超重/肥胖与ER-肿瘤风险升高相关(OR 1.53,95%CI 1.18-1.98)。
- 子宫切除术与ER+肿瘤风险升高相关(OR 4.99,95%CI 4.27-5.83),且随AR表达而异(P异质性=0.003)。
- 绝经后与PR-肿瘤风险升高相关(OR 1.52,95%CI 1.26-1.83),且随AR表达(P异质性<0.001)和ER表达(P异质性<0.001)而异。
- 妊娠次数、口服避孕持续时间及母乳喂养持续时间根据AR/ER/PR表达显示不同的剂量-反应关系。
- 激素治疗使用、绝经后、缺乏体力活动及诊断前超重/肥胖与生存的关联因AR/ER/PR表达和组织学类型而异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Many epithelial ovarian cancer (EOC) risk factors relate to sex hormones. The association between these factors and the expression of androgen receptor (AR), estrogen receptor-α (ER), and progesterone receptor (PR) in tumors is unknown. METHOD: We linked epidemiologic, AR/ER/PR tumor expression, and survival data from 19 studies in the Ovarian Cancer Association Consortium (OCAC; 4762 cases, 20,888 controls) and the Ovarian Tumor Tissue Analysis (OTTA) consortium (5737 cases). We estimated odds ratios (ORs) and 95 % confidence intervals (CIs) between hormonally-linked factors and tumor AR/ER/PR expression using polytomous logistic regression. We assessed survival by AR/ER/PR tumor expression overall and by histotype using Kaplan-Meier curves and Cox proportional hazards models. RESULTS: Overweight/obesity was associated with higher risk of ER- tumors (OR:1.53, 95 % I:1.18-1.98). Hysterectomy was associated with greater risk of ER+ tumors (OR:4.99, 95 % CI:4.27-5.83), which varied by AR expression (Pheter=0.003). Postmenopause was associated with a higher risk of PR- tumors (OR 1.52, 95 % CI 1.26-1.83), which varied based by AR (Pheter < 0.001) and ER (Pheter < 0.001) expression. Gravidity, oral contraception duration, and breastfeeding duration showed differing dose-response relationships according to AR/ER/PR expression. Hormone therapy use, postmenopause, physical inactivity, and being obese/overweight prior to diagnosis were differentially associated with survival based on AR/ER/PR expression and histotype. CONCLUSION: EOC has varying risk and prognostic profiles depending on both histotype and AR/ER/PR expression. Biological mechanisms underlying the association between hormonally-linked factors and EOC need to be studied by both histotypes and by AR, ER, and PR expression.
引用
- Fu Z, Borho L, Taylor SE, et al. Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis. Gynecol Oncol. 2025. PMID: 40482607. doi:10.1016/j.ygyno.2025.05.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。